Showing results (2891-2900 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|September 22, 2020
Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient OutcomesHui Xu, Maosheng Lin, Yingying Hu, et al.
The Oncologist|September 12, 2020
Targetable BRAF and RAF1 Alterations in Advanced Pediatric CancersAndrew Rankin, Adrienne Johnson, Alison Roos, et al.
The Oncologist|September 12, 2020
Cost-Effectiveness of Pembrolizumab plus Axitinib Versus Sunitinib as First-Line Therapy in Advanced Renal Cell Carcinoma in the U.SDong Ding, Huabin Hu, Yin Shi, et al.
The Oncologist|September 12, 2020
Phase I/II Study of Cisplatin plus Nab-Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non-Small Cell Lung CancerHidetoshi Hayashi, Masakazu Ogura, Takashi Niwa, et al.
The Oncologist|April 7, 2020
Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health InitiativeKerryn W Reding, Aaron K Aragaki, Richard K Cheng, et al.
The Oncologist|October 3, 2020
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine-Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX-BC Study)Naohiro Okano, Junji Furuse, Makoto Ueno, et al.
The Oncologist|March 27, 2020
Impact on Health-Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled TrialCarole Bouleuc, Amélie Anota, Cécile Cornet, et al.
The Oncologist|January 31, 2020
Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral CenterJessica J Jalbert, Roman Casciano, Jie Meng, et al.
The Oncologist|October 26, 2020
A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients with Advanced Solid MalignanciesRuben S A Goedegebuure, Madelon Q Wentink, Hans J van der Vliet, et al.
The Oncologist|June 6, 2022
Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination TherapyEmily J Anstadt, Brian Chu, Nikhil Yegya-Raman, et al.
Pageof 571